Publication: The synthesis and antitubercular activity of substituted hydrazone,2-pyrazoline-5-one and 2-isoxazoline-5-one derivatives possessing 1,3,4-thiadiazole moiety [1,3,4-Tiyadiazol halkası içeren hidrazon, 2-pirazol-5-on ve 2-izoksazol-5-on türevi bileşiklerin sentezi ve antitüberküler aktiviteleri]
| dc.contributor.authors | Oral B., Rollas S. | |
| dc.date.accessioned | 2022-03-15T02:09:38Z | |
| dc.date.accessioned | 2026-01-10T19:06:50Z | |
| dc.date.available | 2022-03-15T02:09:38Z | |
| dc.date.issued | 2012 | |
| dc.description.abstract | Novel derivatives of substituted hydrazone (2a-e), 2-pyrazoline-5-one (3a-e, 4ae) and 2-isoxazoline-5-one (5a-e) derivatives possessing 1,3,4-thiadiazole moiety were synthesized and evaluated for their antitubercular activity. The highest inhibitions were observed with the synthesized compounds are 87% for 3-methyl-4-[4-(5-cyclohexylamino- 1,3,4-thiadiazole-2-yl)phenylhydrazono]-2-isoxazoline-5-one (5b) and 86% for ethyl 2-[4-(5-cyclohexylamino-1,3,4-thiadiazole-2-yl)phenylhydrazono]-3-oxobutirate (2b). Compounds 2b and 5b could be a good initial point to develop new lead compound. | |
| dc.identifier.doi | 10.12991/201216402 | |
| dc.identifier.issn | 13090801 | |
| dc.identifier.uri | https://hdl.handle.net/11424/247233 | |
| dc.language.iso | eng | |
| dc.publisher | Marmara University | |
| dc.relation.ispartof | Marmara Pharmaceutical Journal | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | 1,3,4-thiadiazole | |
| dc.subject | 2-isoxazoline-5-one | |
| dc.subject | 2-pyrazolin-5-one | |
| dc.subject | Hydrazone and antitubercular activity | |
| dc.title | The synthesis and antitubercular activity of substituted hydrazone,2-pyrazoline-5-one and 2-isoxazoline-5-one derivatives possessing 1,3,4-thiadiazole moiety [1,3,4-Tiyadiazol halkası içeren hidrazon, 2-pirazol-5-on ve 2-izoksazol-5-on türevi bileşiklerin sentezi ve antitüberküler aktiviteleri] | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 228 | |
| oaire.citation.issue | 3 | |
| oaire.citation.startPage | 222 | |
| oaire.citation.title | Marmara Pharmaceutical Journal | |
| oaire.citation.volume | 16 |
